{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Biomarker", "Hepatitis C virus", "Host-virus interaction", "MicroRNAs", "Therapeutic targets"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26819516", "DateCompleted": {"Year": "2017", "Month": "01", "Day": "17"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "ELocationID": ["10.3748/wjg.v22.i4.1487"], "Language": ["eng"], "Journal": {"ISSN": "2219-2840", "JournalIssue": {"Volume": "22", "Issue": "4", "PubDate": {"Year": "2016", "Month": "Jan", "Day": "28"}}, "Title": "World journal of gastroenterology", "ISOAbbreviation": "World J Gastroenterol"}, "ArticleTitle": "MicroRNA-mediated interactions between host and hepatitis C virus.", "Pagination": {"StartPage": "1487", "EndPage": "1496", "MedlinePgn": "1487-96"}, "Abstract": {"AbstractText": ["MicroRNAs (miRNAs) are small noncoding RNAs. More than 2500 mature miRNAs are detected in plants, animals and several types of viruses. Hepatitis C virus (HCV), which is a positive-sense, single-stranded RNA virus, does not encode viral miRNA. However, HCV infection alters the expression of host miRNAs, either in cell culture or in patients with liver disease progression, such as liver fibrosis, cirrhosis, and hepatocellular carcinoma. In turn, host miRNAs regulate HCV life cycle through directly binding to HCV RNAs or indirectly targeting cellular mRNAs. Increasing evidence demonstrates that miRNAs are one of the centered factors in the interaction network between virus and host. The competitive viral and host RNA hypothesis proposes a latent cross-regulation pattern between host mRNAs and HCV RNAs. High loads of HCV RNA sequester and de-repress host miRNAs from their normal host targets and thus disturb host gene expression, indicating a means of adaptation for HCV to establish a persistent infection. Some special miRNAs are closely correlated with liver-specific disease progression and the changed levels of miRNAs are even higher sensitivity and specificity than those of traditional proteins. Therefore, some of them can serve as novel diagnostic/prognostic biomarkers in HCV-infected patients with liver diseases. They are also attractive therapeutic targets for development of new anti-HCV agents."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hu Li, Jian-Dong Jiang, Zong-Gen Peng, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Li", "ForeName": "Hu", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hu Li, Jian-Dong Jiang, Zong-Gen Peng, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Jiang", "ForeName": "Jian-Dong", "Initials": "JD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hu Li, Jian-Dong Jiang, Zong-Gen Peng, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China."}], "LastName": "Peng", "ForeName": "Zong-Gen", "Initials": "ZG"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "World J Gastroenterol", "NlmUniqueID": "100883448", "ISSNLinking": "1007-9327"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA, Viral"}, {"RegistryNumber": "0", "NameOfSubstance": "Genetic Markers"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Viral"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "DNA, Viral"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation, Viral"}, {"QualifierName": [], "DescriptorName": "Genetic Markers"}, {"QualifierName": ["drug effects", "genetics", "growth & development", "metabolism"], "DescriptorName": "Hepacivirus"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "virology"], "DescriptorName": "Hepatitis C"}, {"QualifierName": [], "DescriptorName": "Host-Pathogen Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "MicroRNAs"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Viral"}, {"QualifierName": [], "DescriptorName": "Viral Load"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Yoshida I, Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 1991;65:1105\u20131113.", "ArticleIdList": ["PMC239876", "1847440"]}, {"Citation": "Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333\u20131342.", "ArticleIdList": ["23172780"]}, {"Citation": "Suzuki T, Ishii K, Aizaki H, Wakita T. Hepatitis C viral life cycle. Adv Drug Deliv Rev. 2007;59:1200\u20131212.", "ArticleIdList": ["17825945"]}, {"Citation": "Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77\u201387.", "ArticleIdList": ["PMC4303918", "25069599"]}, {"Citation": "Yang Z, Yu Y, Zhang H, Shang G, Gao J, Jiang JD, Peng Z. Replication priority of hepatitis C virus genotype 2a in a Chinese cohort. Acta Pharm Sin B. 2014;4:266\u2013269.", "ArticleIdList": ["PMC4629081", "26579394"]}, {"Citation": "Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843\u2013854.", "ArticleIdList": ["8252621"]}, {"Citation": "Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68\u2013D73.", "ArticleIdList": ["PMC3965103", "24275495"]}, {"Citation": "Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, R\u00e5dmark O, Kim S, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415\u2013419.", "ArticleIdList": ["14508493"]}, {"Citation": "Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u2013233.", "ArticleIdList": ["PMC3794896", "19167326"]}, {"Citation": "Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12:99\u2013110.", "ArticleIdList": ["21245828"]}, {"Citation": "Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol. 2012;19:586\u2013593.", "ArticleIdList": ["22664986"]}, {"Citation": "Ambros V. The functions of animal microRNAs. Nature. 2004;431:350\u2013355.", "ArticleIdList": ["15372042"]}, {"Citation": "Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320.", "ArticleIdList": ["15652477"]}, {"Citation": "Lee CH, Kim JH, Lee SW. The role of microRNAs in hepatitis C virus replication and related liver diseases. J Microbiol. 2014;52:445\u2013451.", "ArticleIdList": ["24871972"]}, {"Citation": "Lindenbach BD, Evans MJ, Syder AJ, W\u00f6lk B, Tellinghuisen TL, Liu CC, Maruyama T, Hynes RO, Burton DR, McKeating JA, et al. Complete replication of hepatitis C virus in cell culture. Science. 2005;309:623\u2013626.", "ArticleIdList": ["15947137"]}, {"Citation": "Liu X, Wang T, Wakita T, Yang W. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology. 2010;398:57\u201367.", "ArticleIdList": ["20006370"]}, {"Citation": "Ishida H, Tatsumi T, Hosui A, Nawa T, Kodama T, Shimizu S, Hikita H, Hiramatsu N, Kanto T, Hayashi N, et al. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway. Biochem Biophys Res Commun. 2011;412:92\u201397.", "ArticleIdList": ["21802413"]}, {"Citation": "Zhang X, Daucher M, Armistead D, Russell R, Kottilil S. MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-\u03b1. PLoS One. 2013;8:e55733.", "ArticleIdList": ["PMC3572124", "23418453"]}, {"Citation": "Ramachandran S, Ilias Basha H, Sarma NJ, Lin Y, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS One. 2013;8:e70744.", "ArticleIdList": ["PMC3741284", "23950995"]}, {"Citation": "Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut. 2012;61:1600\u20131609.", "ArticleIdList": ["22267590"]}, {"Citation": "Bandyopadhyay S, Friedman RC, Marquez RT, Keck K, Kong B, Icardi MS, Brown KE, Burge CB, Schmidt WN, Wang Y, et al. Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J Infect Dis. 2011;203:1753\u20131762.", "ArticleIdList": ["PMC3143452", "21606534"]}, {"Citation": "Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53:209\u2013218.", "ArticleIdList": ["20890893"]}, {"Citation": "Sarma NJ, Tiriveedhi V, Subramanian V, Shenoy S, Crippin JS, Chapman WC, Mohanakumar T. Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One. 2012;7:e50826.", "ArticleIdList": ["PMC3511274", "23226395"]}, {"Citation": "Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest. 2010;90:1727\u20131736.", "ArticleIdList": ["20625373"]}, {"Citation": "Negrini M, Gramantieri L, Sabbioni S, Croce CM. microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem. 2011;11:500\u2013521.", "ArticleIdList": ["21554203"]}, {"Citation": "Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006;25:2537\u20132545.", "ArticleIdList": ["16331254"]}, {"Citation": "Diaz G, Melis M, Tice A, Kleiner DE, Mishra L, Zamboni F, Farci P. Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma. Int J Cancer. 2013;133:816\u2013824.", "ArticleIdList": ["PMC3830961", "23390000"]}, {"Citation": "Chen JS, Wang Q, Fu XH, Huang XH, Chen XL, Cao LQ, Chen LZ, Tan HX, Li W, Bi J, et al. Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res. 2009;39:177\u2013186.", "ArticleIdList": ["19208038"]}, {"Citation": "Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell. 2011;19:232\u2013243.", "ArticleIdList": ["21316602"]}, {"Citation": "Kim S, Lee UJ, Kim MN, Lee EJ, Kim JY, Lee MY, Choung S, Kim YJ, Choi YC. MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2) J Biol Chem. 2008;283:18158\u201318166.", "ArticleIdList": ["18456660"]}, {"Citation": "Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2010;70:5184\u20135193.", "ArticleIdList": ["20501828"]}, {"Citation": "Fukuhara T, Matsuura Y. Role of miR-122 and lipid metabolism in HCV infection. J Gastroenterol. 2013;48:169\u2013176.", "ArticleIdList": ["PMC3698423", "22965312"]}, {"Citation": "Skalsky RL, Cullen BR. Viruses, microRNAs, and host interactions. Annu Rev Microbiol. 2010;64:123\u2013141.", "ArticleIdList": ["PMC3621958", "20477536"]}, {"Citation": "Murakami Y, Aly HH, Tajima A, Inoue I, Shimotohno K. Regulation of the hepatitis C virus genome replication by miR-199a. J Hepatol. 2009;50:453\u2013460.", "ArticleIdList": ["19144437"]}, {"Citation": "Cheng JC, Yeh YJ, Tseng CP, Hsu SD, Chang YL, Sakamoto N, Huang HD. Let-7b is a novel regulator of hepatitis C virus replication. Cell Mol Life Sci. 2012;69:2621\u20132633.", "ArticleIdList": ["22391672"]}, {"Citation": "Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature. 2007;449:919\u2013922.", "ArticleIdList": ["PMC2748825", "17943132"]}, {"Citation": "Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 2005;309:1577\u20131581.", "ArticleIdList": ["16141076"]}, {"Citation": "Huang MH, Jiang JD, Peng ZG. Recent advances in the anti-HCV mechanisms of interferon. Acta Pharmaceutica Sinica B. 2014;4:241\u2013247.", "ArticleIdList": ["PMC4629091", "26579391"]}, {"Citation": "Lindsay MA. microRNAs and the immune response. Trends Immunol. 2008;29:343\u2013351.", "ArticleIdList": ["18515182"]}, {"Citation": "Wilkins C, Woodward J, Lau DT, Barnes A, Joyce M, McFarlane N, McKeating JA, Tyrrell DL, Gale M. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology. 2013;57:461\u2013469.", "ArticleIdList": ["PMC3566288", "22996292"]}, {"Citation": "Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol. 2012;86:10221\u201310225.", "ArticleIdList": ["PMC3446586", "22787204"]}, {"Citation": "Mukherjee A, Di Bisceglie AM, Ray RB. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway. J Virol. 2015;89:3356\u20133365.", "ArticleIdList": ["PMC4337546", "25589644"]}, {"Citation": "Yoshimura A, Suzuki M, Sakaguchi R, Hanada T, Yasukawa H. SOCS, Inflammation, and Autoimmunity. Front Immunol. 2012;3:20.", "ArticleIdList": ["PMC3342034", "22566904"]}, {"Citation": "Liu Z, Tian Y, Machida K, Lai MM, Luo G, Foung SK, Ou JH. Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry. J Biol Chem. 2012;287:41922\u201341930.", "ArticleIdList": ["PMC3516739", "23095753"]}, {"Citation": "Shwetha S, Gouthamchandra K, Chandra M, Ravishankar B, Khaja MN, Das S. Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis. Sci Rep. 2013;3:1555.", "ArticleIdList": ["PMC3615409", "23549102"]}, {"Citation": "Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M, Ye J. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA. 2007;104:5848\u20135853.", "ArticleIdList": ["PMC1829327", "17376867"]}, {"Citation": "Hishiki T, Shimizu Y, Tobita R, Sugiyama K, Ogawa K, Funami K, Ohsaki Y, Fujimoto T, Takaku H, Wakita T, et al. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms. J Virol. 2010;84:12048\u201312057.", "ArticleIdList": ["PMC2977863", "20826689"]}, {"Citation": "Mancone C, Steindler C, Santangelo L, Simonte G, Vlassi C, Longo MA, D\u2019Offizi G, Di Giacomo C, Pucillo LP, Amicone L, et al. Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins. Gut. 2011;60:378\u2013386.", "ArticleIdList": ["20940285"]}, {"Citation": "Shirasaki T, Honda M, Shimakami T, Horii R, Yamashita T, Sakai Y, Sakai A, Okada H, Watanabe R, Murakami S, et al. MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J Virol. 2013;87:5270\u20135286.", "ArticleIdList": ["PMC3624309", "23449803"]}, {"Citation": "Kr\u00fctzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature. 2005;438:685\u2013689.", "ArticleIdList": ["16258535"]}, {"Citation": "Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87\u201398.", "ArticleIdList": ["16459310"]}, {"Citation": "Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010;20:589\u2013599.", "ArticleIdList": ["PMC2860161", "20439436"]}, {"Citation": "Li C, Hu J, Hao J, Zhao B, Wu B, Sun L, Peng S, Gao GF, Meng S. Competitive virus and host RNAs: the interplay of a hidden virus and host interaction. Protein Cell. 2014;5:348\u2013356.", "ArticleIdList": ["PMC3996157", "24723323"]}, {"Citation": "Ala U, Karreth FA, Bosia C, Pagnani A, Taulli R, L\u00e9opold V, Tay Y, Provero P, Zecchina R, Pandolfi PP. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc Natl Acad Sci USA. 2013;110:7154\u20137159.", "ArticleIdList": ["PMC3645534", "23536298"]}, {"Citation": "Li C, Wang Y, Wang S, Wu B, Hao J, Fan H, Ju Y, Ding Y, Chen L, Chu X, et al. Hepatitis B virus mRNA-mediated miR-122 inhibition upregulates PTTG1-binding protein, which promotes hepatocellular carcinoma tumor growth and cell invasion. J Virol. 2013;87:2193\u20132205.", "ArticleIdList": ["PMC3571498", "23221562"]}, {"Citation": "Lee S, Song J, Kim S, Kim J, Hong Y, Kim Y, Kim D, Baek D, Ahn K. Selective degradation of host MicroRNAs by an intergenic HCMV noncoding RNA accelerates virus production. Cell Host Microbe. 2013;13:678\u2013690.", "ArticleIdList": ["23768492"]}, {"Citation": "Marcinowski L, Tanguy M, Krmpotic A, R\u00e4dle B, Lisni\u0107 VJ, Tuddenham L, Chane-Woon-Ming B, Ruzsics Z, Erhard F, Benkartek C, et al. Degradation of cellular mir-27 by a novel, highly abundant viral transcript is important for efficient virus replication in vivo. PLoS Pathog. 2012;8:e1002510.", "ArticleIdList": ["PMC3276556", "22346748"]}, {"Citation": "Cazalla D, Yario T, Steitz JA. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science. 2010;328:1563\u20131566.", "ArticleIdList": ["PMC3075239", "20558719"]}, {"Citation": "Luna JM, Scheel TK, Danino T, Shaw KS, Mele A, Fak JJ, Nishiuchi E, Takacs CN, Catanese MT, de Jong YP, et al. Hepatitis C virus RNA functionally sequesters miR-122. Cell. 2015;160:1099\u20131110.", "ArticleIdList": ["PMC4386883", "25768906"]}, {"Citation": "Nasheri N, Singaravelu R, Goodmurphy M, Lyn RK, Pezacki JP. Competing roles of microRNA-122 recognition elements in hepatitis C virus RNA. Virology. 2011;410:336\u2013344.", "ArticleIdList": ["21185047"]}, {"Citation": "Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology. 2007;133:1166\u20131174.", "ArticleIdList": ["PMC2128739", "17919492"]}, {"Citation": "Hatzoglou M, Fernandez J, Yaman I, Closs E. Regulation of cationic amino acid transport: the story of the CAT-1 transporter. Annu Rev Nutr. 2004;24:377\u2013399.", "ArticleIdList": ["15459982"]}, {"Citation": "Jopling CL, Norman KL, Sarnow P. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122. Cold Spring Harb Symp Quant Biol. 2006;71:369\u2013376.", "ArticleIdList": ["17381319"]}, {"Citation": "Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, et al. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009;69:5761\u20135767.", "ArticleIdList": ["19584283"]}, {"Citation": "Xu H, He JH, Xiao ZD, Zhang QQ, Chen YQ, Zhou H, Qu LH. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010;52:1431\u20131442.", "ArticleIdList": ["20842632"]}, {"Citation": "Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2008;375:315\u2013320.", "ArticleIdList": ["18692484"]}, {"Citation": "Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, Yadav A, Nuovo G, Kumar P, Ghoshal K. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 2009;284:32015\u201332027.", "ArticleIdList": ["PMC2797273", "19726678"]}, {"Citation": "Hou W, Tian Q, Zheng J, Bonkovsky HL. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology. 2010;51:1494\u20131504.", "ArticleIdList": ["PMC2862129", "20127796"]}, {"Citation": "Shrivastava S, Petrone J, Steele R, Lauer GM, Di Bisceglie AM, Ray RB. Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology. 2013;58:863\u2013871.", "ArticleIdList": ["PMC3664107", "23390075"]}, {"Citation": "Abdalla MA, Haj-Ahmad Y. Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients. J Cancer. 2012;3:19\u201331.", "ArticleIdList": ["PMC3245605", "22211142"]}, {"Citation": "Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D, Szabo G. Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med. 2012;10:151.", "ArticleIdList": ["PMC3477071", "22846613"]}, {"Citation": "Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, Sun S. Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology. 2012;56:1631\u20131640.", "ArticleIdList": ["22610915"]}, {"Citation": "Ka\u0142u\u017cna EM. MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection? Rev Med Virol. 2014;24:169\u2013185.", "ArticleIdList": ["24591085"]}, {"Citation": "Riad SE, El-Ekiaby N, Mekky RY, Ahmed R, El Din MA, El-Sayed M, Abouelkhair MM, Salah A, Zekri AR, Esmat G, et al. Expression signature of microRNA-155 in hepatitis C virus genotype 4 infection. Biomed Rep. 2015;3:93\u201397.", "ArticleIdList": ["PMC4251265", "25469255"]}, {"Citation": "Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368:1685\u20131694.", "ArticleIdList": ["23534542"]}, {"Citation": "Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007;8:166.", "ArticleIdList": ["PMC1904203", "17565689"]}, {"Citation": "Pietschmann T. Regulation of hepatitis C virus replication by microRNAs. J Hepatol. 2009;50:441\u2013444.", "ArticleIdList": ["19155089"]}, {"Citation": "Almeida MI, Reis RM, Calin GA. Decoy activity through microRNAs: the therapeutic implications. Expert Opin Biol Ther. 2012;12:1153\u20131159.", "ArticleIdList": ["PMC3799811", "22650365"]}, {"Citation": "Seo H, Kim W, Lee J, Youn B. Network-based approaches for anticancer therapy (Review) Int J Oncol. 2013;43:1737\u20131744.", "ArticleIdList": ["24085339"]}, {"Citation": "Giza DE, Vasilescu C, Calin GA. MicroRNAs and ceRNAs: therapeutic implications of RNA networks. Expert Opin Biol Ther. 2014;14:1285\u20131293.", "ArticleIdList": ["24941322"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "7", "Day": "20"}, {"Year": "2015", "Month": "9", "Day": "25"}, {"Year": "2015", "Month": "10", "Day": "12"}, {"Year": "2016", "Month": "1", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "1", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "1", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26819516", "PMC4721982", "10.3748/wjg.v22.i4.1487"]}}], "PubmedBookArticle": []}